Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Anghelescu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Alcoholism, Clinical and Experimental Research|May 8, 2000
Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patientsA Szegedi, M J Müller, H Himmerich, et al.
Psychiatric Genetics|September 20, 2000
Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association studyC Fehr, A Szegedi, I Anghelescu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trialI Anghelescu, A Szegedi, S Schlegel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 11, 2001
Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsyC Fehr, A Schleicher, A Szegedi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 28, 2000
Adenylyl cyclase activity is increased in younger, but decreased in older, alcoholic patients after detoxificationN Dahmen, T Pauly, A Szegedi, et al.
Journal of Clinical Psychopharmacology|February 24, 1998
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective studyH Wetzel, I Anghelescu, A Szegedi, et al.
Schizophrenia Research|June 29, 2001
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patientsN Dahmen, M J Müller, S Germeyer, et al.
Alcoholism, Clinical and Experimental Research|January 12, 1999
Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependentA Szegedi, I Anghelescu, T Pauly, et al.
Neuropsychobiology|September 11, 2002
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levelsR Schlösser, G Gründer, I Anghelescu, et al.
European Addiction Research|December 21, 2004
Reliability and validity of the form 90 interviewA Scheurich, M J Müller, I Anghelescu, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Alcoholism, Clinical and Experimental Research|May 8, 2000
Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patientsA Szegedi, M J Müller, H Himmerich, et al.
Psychiatric Genetics|September 20, 2000
Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association studyC Fehr, A Szegedi, I Anghelescu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trialI Anghelescu, A Szegedi, S Schlegel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 11, 2001
Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsyC Fehr, A Schleicher, A Szegedi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 28, 2000
Adenylyl cyclase activity is increased in younger, but decreased in older, alcoholic patients after detoxificationN Dahmen, T Pauly, A Szegedi, et al.
Journal of Clinical Psychopharmacology|February 24, 1998
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective studyH Wetzel, I Anghelescu, A Szegedi, et al.
Schizophrenia Research|June 29, 2001
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patientsN Dahmen, M J Müller, S Germeyer, et al.
Alcoholism, Clinical and Experimental Research|January 12, 1999
Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependentA Szegedi, I Anghelescu, T Pauly, et al.
Neuropsychobiology|September 11, 2002
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levelsR Schlösser, G Gründer, I Anghelescu, et al.
European Addiction Research|December 21, 2004
Reliability and validity of the form 90 interviewA Scheurich, M J Müller, I Anghelescu, et al.
Pageof 4